Researchers have learned a lot about the human immunodeficiency virus (HIV) and the disease it causes. But still more research is needed to fight the global HIV/AIDS pandemic.
Last year was a remarkable year for recognition of women researchers, as Nobel Prize for Chemistry was unprecedentedly granted to two female scientists, Jennifer Doudna and Emmanuelle Charpentier, for their endeavor of developing CRISPR. However, there are still a lot of women who ...Learn More
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as an extended release complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults. This is the first FDA-approved ...Learn More
HIV causes AIDS and interferes with the body's ability to fight infections.
More than 40 million people are infected with HIV. While the rate of new infections has decreased, and effective antiretroviral drug therapy is available, resource-poor settings in regions of the developing may limit the access to lifesaving drugs. Hence, in the absence of drug ...Learn More
More than 35 years have passed since the first reported cases of AIDS and the discovery of HIV, and despite tremendous efforts no vaccine has been developed that could effectively protect against HIV infection in the vast majority of people. Similarly, there is no treatment ...Learn More